DLEU2L and pancreatic neoplasm: Based on this result and our previous findings (Yang et al., 2019), we next assumed that DLEU2L plays a tumor-suppressing role, particularly in pancreatic cancer, as a target of (and in turn, by targeting) miR-210-3p.